Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine)

被引:39
作者
Dodick, D. W. [1 ]
机构
[1] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ USA
关键词
Migraine complications; migrainous infarct; chronic migraine; comorbidities; risk factors; migraine review; CHRONIC DAILY HEADACHE; EARLY INTERVENTION; ISCHEMIC-STROKE; PAIN INTENSITY; OBESITY; DISEASE; ANXIETY; ALMOTRIPTAN; RIZATRIPTAN; DEPRESSION;
D O I
10.1111/j.1468-2982.2009.02028.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
A number of comorbid disorders, behavioural traits and associated risk factors in patients with migraine are known to increase the risk of complications such as ischaemic vascular events and chronic migraine, a syndrome that is more disabling and resistant to treatment with acute and preventative medications than episodic migraine. Reduction of cardiovascular risk factors, smoking cessation and use of non-oestrogen-containing oral contraceptives in female patients are beneficial strategies to reduce the risk of ischaemic events in patients with migraine (especially those with aura). Attack frequency, acute medication overuse, obesity and coexisting depression and anxiety disorders are particularly strong but potentially modifiable independent risk factors for progression to chronic migraine. Identifying and managing comorbidities and associated risk factors for complications of migraine are likely to require an integrated disease management strategy involving several disciplines and allied health services. Such a disease-oriented model of care may potentially interrupt the cycle of progression and disability and improve quality of life for patients with migraine.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 48 条
[1]
Behavioral medicine for migraine and medication overuse headache [J].
Andrasik, Frank ;
Buse, Dawn C. ;
Grazzi, Licia .
CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (03) :241-248
[2]
[Anonymous], 2004, MED EL CRIT CONTR US, VThird
[3]
[Anonymous], 2006, Obstet Gynecol, DOI [10.1097/00006250-200606000-00055, DOI 10.1097/00006250-200606000-00055.PUBMED:16738183, DOI 10.1097/00006250-200606000-00055]
[4]
Apkarian A Vania, 2004, Novartis Found Symp, V261, P239
[5]
Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study [J].
Bigal, Marcelo E. ;
Serrano, Daniel ;
Buse, Dawn ;
Scher, Ann ;
Stewart, Walter F. ;
Lipton, Richard B. .
HEADACHE, 2008, 48 (08) :1157-1168
[6]
The prognosis of migraine [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
CURRENT OPINION IN NEUROLOGY, 2008, 21 (03) :301-308
[7]
Body mass index and episodic headaches - A population-based study [J].
Bigal, Marcelo E. ;
Tsang, Amy ;
Loder, Elizabeth ;
Serrano, Daniel ;
Reed, Michael L. ;
Lipton, Richard B. .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (18) :1964-1970
[8]
Obesity, migraine, and chronic migraine - Possible mechanisms of interaction [J].
Bigal, Marcelo E. ;
Lipton, Richard B. ;
Holland, Philip R. ;
Goadsby, Peter J. .
NEUROLOGY, 2007, 68 (21) :1851-1861
[9]
Obesity is a risk factor for transformed migraine but not chronic tension-type headache [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
NEUROLOGY, 2006, 67 (02) :252-257
[10]
Excessive acute migraine medication use and migraine progression [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
NEUROLOGY, 2008, 71 (22) :1821-1828